Editas Medicine, Inc. is a company in the U.S. stock market and it is a holding in 63 U.S.-traded ETFs. EDIT has around 12.7M shares in the U.S. ETF market. The largest ETF holder of EDIT is the ARK Innovation ETF (ARKK), with approximately 4.30M shares. Investors may also find of interest that the ETF with the largest allocation to EDIT stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 3.95%. On average, U.S. ETFs allocate 0.35% of EDIT to their portfolios.
Additionally, EDIT is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with EDIT as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.